Sirtex Medical Chairman steps down after 13 years

Company News

by Jessica Amir

Sirtex Medical (ASX:SRX) has announced Richard Hill will retire as Chairman and Non-Executive Director, standing down from the helm on 28 October 2017.

The Australian medical company, providing radioactive treatment in inoperable liver cancer says, Deputy Chairman, Dr John Eady, will assume the role of interim Chairman until a permanent replacement is found.

The outgoing Chairman leaves the group after 13 years. In that time Richard helped the company gain presence in over 40 countries.

He also leaves the company with $118 million in cash and no debt as at FY17.

Shares in Sirtex Medical (ASX:SRX) are trading 0.14 per cent lower to $14.60.
 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.